ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/18/2026
Back to search
Official data from USPTO
LEVALTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LEVALTA
ST13
US500000090669891Class
3, 5, 10
Filing
90669891
Registration
7602935
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
02/19/2026
Trademark type
Word
Nice classes
3, 5, 10
Filing date
04/25/2021
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
02/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
DUBLIN, IE
Examiner
FOSTER, ALEXANDRA M.
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Bausch Health Ireland Limited
Representatives
Jeremy Blackowicz Bausch Health Companies
Technical classification
Nice Classes
Class 3Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Non-medicated preparations for the skinmoisturizerscreamsbody powdersgelsshampoosspraysbody washes; Non-medicated dental rinses for oral health
Class 5
Topical antibiotics to treat atopic dermatitisactinic keratosisacnerosaceapsoriasisathlete's footnail fungus and other skin ailmentsconditions and dermatoses; Pharmaceutical preparations and substances for diagnosis and treatment of oral diseaseperiodontitisoral mucousitis and bone and soft tissue regeneration; Medicated dental rinse for oral health; Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipationhepatic encephalopathyirritable bowel syndromeopioid induced constipation and ulcerative colitis; Medicated beveragespowdersgels for colonoscopies and endoscopic procedures; Pharmaceutical preparations and substances to prevent and treat diabetes mellitusepilepsymigrainesanxiety and depressionchronic painheadachespsychiatric disordersrare diseases in the nature of Wilson and Huntington's diseasediabetes mellituscardiovascular/anginahyperammonaemiahormone deficiencies (endocrinology)cancerotolaryngologyurinary tractlungsheart infections and diseasescentral nervous system disordersneuromuscular conditionsvaginal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of skin and nail conditionsacnepsoriasisonychomycosistinea pedisactinic keratosisrosacea and other dermatosesfungal infections; Vitamins and mineral supplements; Non-medicated dermatologic substances and preparations for the skinointments to treat atopic dermatitisactinic keratosisacnerosaceapsoriasisathlete's footnail fungus and other skin ailmentsconditions and dermatoses; Non-medicated oral health substances preparations in the form of tooth and mouth powderscreamsrinses for the treatment of periodontitismouth drynesscold soresmouth ulcers; Cotton swabs impregnated with non-medicated dermatologic skin care preparations for treating atopic dermatitisactinic keratosisacnerosaceapsoriasisathlete's footnail fungus and other skin ailmentsconditions and dermatoses
Class 10
Radio frequency medical devices for contracting skinbody sculptingsoft tissue reconstruction in a non-invasive manner; Medical devices for aesthetic and therapeutic applications for the skin and its subcutaneous structuresa device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency devices for medical and aesthetic treatment; Medical devicesmedical instruments designed for the non-invasive removal of human body fat using an external energy source
Publications
History of USPTO decisions and trademark events.
65 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/11/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/29/2024
PUBO
PUBLISHED FOR OPPOSITION
10/29/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2024
OTHE
CASE RETURNED TO EXAMINATION
09/04/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/04/2024
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
09/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/19/2024
EX2G
SOU EXTENSION 2 GRANTED
08/19/2024
EXT2
SOU EXTENSION 2 FILED
08/19/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/19/2024
APET
ASSIGNED TO PETITION STAFF
08/13/2024
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
07/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/13/2024
EX1G
SOU EXTENSION 1 GRANTED
02/12/2024
EXT1
SOU EXTENSION 1 FILED
02/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/12/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/22/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/19/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/10/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/09/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/09/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/09/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/09/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/09/2023
GNFR
FINAL REFUSAL E-MAILED
05/09/2023
CNFR
FINAL REFUSAL WRITTEN
05/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/08/2023
ALIE
ASSIGNED TO LIE
05/08/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/18/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/28/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/14/2022
GRML
CORRESPONDENCE E-MAILED
08/22/2022
CNRT
NON-FINAL ACTION WRITTEN
08/22/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/22/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/25/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/04/2022
DOCK
ASSIGNED TO EXAMINER
06/29/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/01/2021
GNRT
NON-FINAL ACTION E-MAILED
12/01/2021
CNRT
NON-FINAL ACTION WRITTEN
12/01/2021
DOCK
ASSIGNED TO EXAMINER
12/01/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/16/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/16/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/30/2021
NWAP
NEW APPLICATION ENTERED
04/28/2021
Continuous trademark protection
Get notified about every new filing that threatens LEVALTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.